Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone for Prevention of PHN in Acute Herpes Zoster
NCT03120962Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2017
- Primary completion
- May 2020
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of oxycodone in herpes zoster (HZ) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Proportion of patients with zoster pain at 3 months. Status: unknown.
02
Drugs
oxycodone
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03120962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120962.